Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Pediatric Diabetes
|
November 2, 2022
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
Janne Houben, Martha Janssens, Christiane Winkler, et al.
BMJ Paediatrics Open
|
January 12, 2024
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study
An Jacobs, Maarten Warnants, Veronika Vollmuth, et al.
Contemporary Clinical Trials Communications
|
February 7, 2025
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol
Sandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
Infection
|
June 14, 2024
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
Ivo Zeller, Andreas Weiss, Stefanie Arnolds, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Further molecular characterisation of the OVT73 transgenic sheep model of Huntington's disease identifies cortical aggregates
, Suzanne J Reid, Stefano Patassini, et al.
The Journal of Clinical Investigation
|
October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
Katharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Diabetologia
|
January 12, 2024
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
Sandra Hummel, Sarah Rosenberger, Thekla von dem Berge, et al.
Brain : a Journal of Neurology
|
January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation
Ulrike Träger, Ralph Andre, Nayana Lahiri, et al.
Plos One
|
March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtin
Wolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Journal of Medicinal Chemistry
|
November 20, 2020
Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
Jean Quancard, Oliver Simic, Carole Pissot Soldermann, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Pediatric Diabetes
|
November 2, 2022
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
Janne Houben, Martha Janssens, Christiane Winkler, et al.
BMJ Paediatrics Open
|
January 12, 2024
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes: a secondary analysis of the POInT Study
An Jacobs, Maarten Warnants, Veronika Vollmuth, et al.
Contemporary Clinical Trials Communications
|
February 7, 2025
Anti-viral action against type 1 diabetes autoimmunity: The GPPAD-AVAnT1A study protocol
Sandra Hummel, Alexandra Käßl, Stefanie Arnolds, et al.
Infection
|
June 14, 2024
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
Ivo Zeller, Andreas Weiss, Stefanie Arnolds, et al.
Journal of Huntington'S Disease
|
July 27, 2014
Further molecular characterisation of the OVT73 transgenic sheep model of Huntington's disease identifies cortical aggregates
, Suzanne J Reid, Stefano Patassini, et al.
The Journal of Clinical Investigation
|
October 17, 2022
Elevations in blood glucose before and after the appearance of islet autoantibodies in children
Katharina Warncke, Andreas Weiss, Peter Achenbach, et al.
Diabetologia
|
January 12, 2024
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
Sandra Hummel, Sarah Rosenberger, Thekla von dem Berge, et al.
Brain : a Journal of Neurology
|
January 25, 2014
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation
Ulrike Träger, Ralph Andre, Nayana Lahiri, et al.
Plos One
|
March 27, 2019
Meso scale discovery-based assays for the detection of aggregated huntingtin
Wolfgang Reindl, Barbara Baldo, Jana Schulz, et al.
Journal of Medicinal Chemistry
|
November 20, 2020
Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood
Jean Quancard, Oliver Simic, Carole Pissot Soldermann, et al.
Page
of 11